Literature DB >> 12394820

Extended spectrum beta-lactamases: a therapeutic dilemma.

Jan E Patterson1.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12394820     DOI: 10.1097/00006454-200210000-00014

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  5 in total

Review 1.  Antibacterial resistance.

Authors:  Jocelyn Y Ang; Elias Ezike; Basim I Asmar
Journal:  Indian J Pediatr       Date:  2004-03       Impact factor: 1.967

2.  Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000-2006.

Authors:  Ferhat Catal; Nuket Bavbek; Omer Bayrak; Musemma Karabel; Duran Karabel; Ender Odemis; Ebru Uz
Journal:  Int Urol Nephrol       Date:  2008-08-14       Impact factor: 2.370

3.  Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous therapy.

Authors:  Maria Haller; Matthias Brandis; Reinhard Berner
Journal:  Pediatr Nephrol       Date:  2004-06-18       Impact factor: 3.714

4.  Extended spectrum beta lactamase producing Klebsiella pneumoniae in neonatal intensive care unit.

Authors:  B V S Krishna; Asha B Patil; M R Chandrasekhar
Journal:  Indian J Pediatr       Date:  2007-07       Impact factor: 1.967

5.  Demographic features and antibiotic resistance among children hospitalized for urinary tract infection in northwest Iran.

Authors:  Ziaaedin Ghorashi; Sona Ghorashi; Hassan Soltani-Ahari; Nariman Nezami
Journal:  Infect Drug Resist       Date:  2011-10-11       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.